Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prodotti Chimici Alimentari (PCA) is a leading Italian pharmaceutical company specializing in the development and manufacture of bile acid derivatives and active pharmaceutical ingredients (APIs). Founded in 1949 and headquartered in Basaluzzo, Italy, the company is a global leader in the production of Ursodeoxycholic Acid (UDCA), used primarily for treating cholestatic liver diseases and gallstones. PCA operates as part of the Bracco Group and maintains high-quality manufacturing standards, including GMP certification. Their product portfolio also includes Chenodeoxycholic Acid (CDCA) and other specialized chemical intermediates for the global pharmaceutical market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prodotti Chimici Alimentari.